Heart rate lowering for coronary CTA with Ivabradine in atrial fibrillation

J Cardiovasc Comput Tomogr. 2024 Jan-Feb;18(1):109-110. doi: 10.1016/j.jcct.2023.10.008. Epub 2023 Oct 20.

Authors

Dzhalal Agakishiev¹, Jose Arriola-Montenegro¹, Rishabh Tandon², Jeremy Markowitz², Felipe Kazmirczak², Prabhjot S Nijjar³

Affiliations

¹ Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.
² Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.
³ Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA. Electronic address: nijja003@umn.edu.

PMID: 37867126
DOI: 10.1016/j.jcct.2023.10.008

No abstract available

Publication types

Letter

MeSH terms

Atrial Fibrillation* / diagnostic imaging
Atrial Fibrillation* / drug therapy
Benzazepines / pharmacology
Benzazepines / therapeutic use
Cardiovascular Agents*
Heart
Heart Rate
Humans
Ivabradine
Predictive Value of Tests

Substances

Ivabradine
Cardiovascular Agents
Benzazepines